Log In
BCIQ
Print this Print this
 

Nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kB) (NFKB1) (p105) (p50)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kB) (NFKB1) (p105) (p50)

BCIQ
Print ChartPrint this
0 1 0 0 0 0 0 0 2 0 1 0 0 0 0 2 0 1 0 0 0 2 0 0 1 0 1 0 0 0 0 1 0 1 0 0 0 0 0 0 2 0 0 1 1 4 1 1 0 0 1 0 1 1 1 1
Phases of DevelopmentDiscoveryPreclinicalINDPhase IPhase I/IIPhase IIMarketed
Autoimmune

0

1

0

1

1

1

1

Cancer

0

1

1

4

1

1

0

Dermatology

0

0

0

0

0

2

0

Endocrine / Metabolic

0

0

0

1

0

1

0

Inflammation

2

0

0

1

0

1

0

Musculoskeletal

0

2

0

1

0

0

0

Neurology

0

2

0

1

0

0

0

Pulmonary

0

1

0

0

0

0

0




 Products Targeting Nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kB) (NFKB1) (p105) (p50)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

6

$287.0M

$35.0M

$237.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today